Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-27

FDA Approved: GLIMEPIRIDE — Supplemental Application (Solco Healthcare U.S., LLC)

View source ↗

Summary

FDA approved a supplemental application for glimepiride from Solco Healthcare U.S., LLC (generic) to market the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)